Editor's PickMarket News

Vuzix says smart glasses expand AR surgical product presence to support shoulder, knee and spine surgeries

Vuzix Corporation (NASDAQ:VUZI) (FRA:V7XN), a leading supplier of smart glasses and augmented reality (AR) technology, has announced its market expansion to support the NextAR surgical AR platform developed by Medacta International, one of the world’s largest providers of orthopedic products. Having used the Vuzix Blade to complete the first smart glasses-based total knee replacement in the US in 2020, Medacta recently received its CE marking for knee, shoulder, and spine applications for its NextAR Augmented Reality Surgical Platform in Europe. A CE Mark indicates that a product fulfills the requirements of relevant European product directives. In addition, the US Food and Drug Administration (FDA) has also cleared the platform’s shoulder application. READ: Vuzix Corporation rises to the ranks of the Russell 2000 and 3000 Indexes “We’re proud to provide the hardware backbone for Medacta’s NextAR platform as it continues to branch into new surgical applications which now include knee, shoulder and spine in Europe and knee and shoulder in the United States,” Vuzix CEO Paul Travers said in a statement. “The Vuzix Smart Glasses are lightweight, comfortable and completely wireless, which means surgeons have complete freedom of movement and can wear them for extended operations,” he added. The Rochester, New York-based company said that the NextAR platform employs a preoperative scan, with proprietary algorithms that create a “personalized biomechanical model for each replacement.” Surgeons equipped with Vuzix Blade Smart Glasses can then access biomechanical visualizations using augmented reality in real-time, without having to divert their eyes from the procedure to glance at a computer screen. “NextAR’s smart delivery tools may improve efficiency in computer-assisted surgery by offering a compact solution that avoids the need for a bulky external detection platform,” noted the company. With a “low upfront capital investment” and overall lower cost per case compared to other technologies, this translates into “greater efficiency in the operating room,” which is particularly relevant for US Ambulatory Surgery Centers (ASCs), the firm added. Vuzix makes and sells two main products – Vuzix Blade Upgraded smart glasses, and the M-series smart glasses. The Vuzix M-Series boasts the new M4000, M400 and cost-effective M300XL. Founded in 1997, Vuzix holds 192 patents, patents pending and numerous IP licenses in the video eyewear field. Contact the author Uttara Choudhury at uttara@proactiveinvestors.com Follow her on Twitter: @UttaraProactive

Leave a Reply

Your email address will not be published. Required fields are marked *